We recently published a list of 10 Worst Booming Stocks to Buy According to Short Sellers. In this article, we are going to ...

We recently published a list of 10 Worst Booming Stocks to Buy According to Short Sellers. In this article, we are going to ...

Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

Warren Buffett's strategy of investing in companies with strong moats can be applied to REITs for building a solid investment ...

US-based financial services company Vanguard Group acquired shares worth Rs 998 crore in seven Indian companies via open market transactions on the NSE. Concurrently, Zurich-based UBS Group AG sold ...

A rather odd week in venture, as the biggest rounds were raised by greentech, business travel and charity startups. Of course ...

With a market capitalization of just $1.9 billion, Recursion still provides a potentially good entry point for investors, but that's only if there are good reasons to think that its strategy will pan ...

Beyond MariTide, Amgen has a rich pipeline with more than 30 phase 3 programs. Some are for existing medicines seeking label ...

Winston-Salem has become a hot bed of science research and innovation, particularly in the medical field.

The 11000 Cedar Startup Incubator, formerly the home of BioEnterprise Inc., is poised to bridge the commercialization gap by ...

The proximity with Case also allows Stubblefield to utilize the relationship with Convelo’s founders when it comes to ...

Healthcare ETFs hold the potential for higher returns, diversification, and exposure to stably growing companies. Therefore, ...